| Comparison of TCDD and PCB CYP1A induction sensitivities in fresh hepatocytes from human donors, sprague-dawley rats, and rhesus monkeys and HepG2 cells JB Silkworth, A Koganti, K Illouz, A Possolo, M Zhao, SB Hamilton Toxicological Sciences 87 (2), 508-519, 2005 | 116 | 2005 |
| Predicting the rate of cognitive decline in aging and early Alzheimer disease S Adak, K Illouz, W Gorman, R Tandon, EA Zimmerman, R Guariglia, ... Neurology 63 (1), 108-114, 2004 | 111 | 2004 |
| Method, system and computer product for prognosis of a medical disorder S Adak, W Gorman, K Illouz US Patent App. 10/446,494, 2004 | 49 | 2004 |
| Interactive graphics-based analysis tool for visualizing reliability of a system and performing reliability analysis thereon B Osborn, R Neagu, A Krupar, J Hershey, K Illouz, C Hansen, M Edgar, ... US Patent App. 09/897,556, 2003 | 47 | 2003 |
| Toxicogenomic Analysis of Gender, Chemical, and Dose Effects in Livers of TCDD-or Aroclor 1254–Exposed Rats Using a Multifactor Linear Model JB Silkworth, EA Carlson, C McCulloch, K Illouz, S Goodwin, TR Sutter Toxicological sciences 102 (2), 291-309, 2008 | 35 | 2008 |
| A multi-level trend-renewal process for modeling systems with recurrence data Z Xu, Y Hong, WQ Meeker, BE Osborn, K Illouz Technometrics 59 (2), 225-236, 2017 | 21 | 2017 |
| Optimal machining parameter selection using a data-driven tool life modeling approach J Karandikar, J Unnikrishnan, A Henderson, K Illouz US Patent 10,564,624, 2020 | 7 | 2020 |
| Method and apparatus for estimating time to failure acceleration factor JE Hershey, BE Osborn, K Illouz, GB Kliman US Patent 6,728,580, 2004 | 6 | 2004 |
| System and method for correcting operational data K Illouz, BE Osborn US Patent App. 13/852,632, 2014 | 3 | 2014 |
| Optimal machining parameter selection using a data-driven tool life modeling approach J Karandikar, J Unnikrishnan, A Henderson, K Illouz US Patent App. 16/774,286, 2020 | | 2020 |
| Method and system for estimating gene expression data A Possolo, J Silkworth, K Illouz US Patent App. 11/087,482, 2006 | | 2006 |
| Development Of More Appropriate PCB And Dioxin Risk TEF Values By Using Fresh Human And Animal Hepatocytes J Silkworth, A Koganti, K Illouz, A Possolo, M Zhao, SB Hamilton Toxicological Sciences 90, 2006 | | 2006 |
| Characterization of human hepatocyte responses to TCDD, PCB 126, and Aroclor 1254 using DNA microarrays K Illouz, J Silkworth, A Koganti, A Possolo, TR Sutter, S Goodwin, ... Toxicologist 90, 315, 2006 | | 2006 |
| Multi-factor analysis of TEQ-equivalent aroclor and tcdd treated rats reveals differential gene expression profiles K Illouz, A Possolo, M Zhao, SB Hamilton, GM Hoffman, Y Huang, ... Toxicologist 78, 246-246, 2004 | | 2004 |
| No evidence of interaction between PCBs and critical developmental factors JB Silkworth, R Hoerl, K Illouz The Journal of pediatrics 142 (5), 593-594, 2003 | | 2003 |
| The Computer Aided Analysis Platform: Empowering Clinicians with Easy to Use Data Analysis Tools W Gorman, K Illouz, S Adak | | 2003 |
